Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Feb 29;14(3):233-5.
doi: 10.1038/ncb2452.

Secreted miRNAs suppress atherogenesis

Affiliations
Comment

Secreted miRNAs suppress atherogenesis

Daniel J Rader et al. Nat Cell Biol. .

Abstract

Endothelial-vascular smooth muscle cell communication has a critical role in cardiovascular homeostasis and the pathogenesis of atherosclerosis. A study now demonstrates extracellular-vesicle-mediated transfer of the atheroprotective microRNAs miR-143/145 between endothelial and vascular smooth muscle cells, providing compelling evidence that intercellular transport of miRNAs can influence a pathological process, namely atherosclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endothelial–VSMC communication through extracellular vesicles of atheroprotective miRNAs. (a) Under laminar flow conditions, endothelial KLF2 is upregulated. This leads to increased expression of miR-143/145 and transport of these miRNAs in extracellular vesicles to arterial VSMCs, where they repress specific target mRNAs involved in differentiation to the synthetic phenotype. As a result, the VSMCs are maintained in the contractile phenotype associated with normal arterial physiology and atheroprotection. (b) Under non-laminar or turbulent flow conditions, endothelial KLF2 is downregulated, leading to decreased expression of miR-143/145, decreased extracellular vesicle transport to VSMCs and de-repression of mRNAs involved in the synthetic phenotype. As a result, the VSMCs transition to the synthetic phenotype associated with atherosclerosis.

Comment on

References

    1. Potente M, Gerhardt H, Carmeliet P. Cell. (2011;146:873–887. - PubMed
    1. Gaengel K, Genove G, Armulik A, Betsholtz C. Arterioscl. Throm. Vasc. (2009;29:630–638. - PubMed
    1. Davis S, et al. Cell. (1996;87:1161–1169. - PubMed
    1. Pardali E, Goumans M-J, ten Dijke P. Trends Cell Biol. (2010;20:556–567. - PubMed
    1. Carvalho RL, et al. J. Cell Sci. (2007;120:4269–4277. - PubMed

MeSH terms